Skip to main content
. 2021 Oct 24;71(6):1443–1451. doi: 10.1007/s00262-021-03083-3

Table 2.

Antitumor activity in evaluable patients (n = 82)

No. (%)
Best response
 Complete response 0
 Partial response 4 (5)
 Stable disease 37 (45)
 Progressive disease 41 (50)
Overall response 4 (5)
Disease control 41 (50)
Median duration of response, months (range)a 5.0 (4.8 to 17.2 +)
Median duration of disease control, months (range)b 6.3 (0.5 to 17.2 +)

aThe Kaplan–Meier method for censored data was used to calculate the duration. The plus sign ( +) indicates no progressive disease by the time of the last assessment

bDisease control was defined as complete response, partial response and stable disease